Charcot-Marie-Tooth Disease Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Assessing Long Term Safety and Tolerability of PXT3003 in Patients With Charcot-Marie-Tooth Disease Type 1A
Condition: Charcot-Marie-Tooth Disease, Type IA Intervention: Drug: PXT3003 Sponsors: Pharnext SA; SynteractHCR; INC Research Not yet recruiting - verified January 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 26, 2016 Category: Research Source Type: clinical trials
